TC
ACH

Towle & Co’s Accendra Health ACH Stock Holding History

Towle & Co’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,247,959
Closed -$5.99M – 56
2025
Q3 		$5.99M Buy
1,247,959
+524,793
+73% +$3.34M 1.51% 39
2025
Q2 		$6.58M Sell
723,166
-74,200
-9% -$547K 1.55% 38
2025
Q1 		$7.2M Buy
797,366
+30,440
+4% +$321K 1.57% 38
2024
Q4 		$10M Sell
766,926
-181,343
-19% -$2.42M 1.72% 31
2024
Q3 		$14.9M Buy
+948,269
New +$14.4M 2.12% 28
2023
Q2 		– Sell
-23,060
Closed -$336K – 63
2023
Q1 		$336K Sell
23,060
-2,860
-11% -$51.2K 0.05% 61
2022
Q4 		$506K Buy
25,920
+8,020
+45% +$156K 0.07% 62
2022
Q3 		$431K Buy
17,900
+380
+2% +$11.7K 0.07% 59
2022
Q2 		$551K Buy
17,520
+8,830
+102% +$320K 0.09% 50
2022
Q1 		$383K Buy
+8,690
New +$373K 0.05% 39

Other funds holding ACH

CCM
Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Towle & Co's ACH Position: Q4 2025 in Review

Towle & Co sold out of Accendra Health (ACH) in Q4 2025, closing a stake of 1,247,959 shares — an estimated $5.99M sold.

Towle & Co first reported a position in ACH in Q1 2022 and held it in 10 quarters. The position peaked at $14.9M in Q3 2024. 168 funds tracked by Wall St. Rank hold ACH as of Q4 2025.

  • Towle & Co reported no remaining Accendra Health position as of Q4 2025 after selling out during the quarter.
  • Towle & Co sold 1,247,959 Accendra Health shares in Q4 2025, an estimated $5.99M.
  • Towle & Co first reported a position in Accendra Health in Q1 2022 and held it in 10 quarters.
  • Towle & Co's Accendra Health position peaked at $14.9M in Q3 2024.
  • 168 funds tracked by Wall St. Rank held Accendra Health as of Q4 2025.

Based on Towle & Co's 13F filing for Q4 2025, filed 12 Feb 2026.